Johnson & Johnson / EN Case No COMP / Bayer / Aventis / Novartis / Case No COMP / Boron Acquisition Corp. / Boron Acquisition LLC / Pfizer / UBC/Schwarz Pharma / Warner-Lambert / Sanofi / Teva Pharmaceutical Industries Limited / Case COMP / Barr Pharmaceuticals Inc. / B. Finished Dose Pharmaceuticals / Ebewe / L1C / Bristol Myers Squibb / /
Country
Germany / Hungary / Estonia / Slovenia / Bulgaria / Latvia / Poland / Norway / Belgium / United States / Slovakia / Liechtenstein / United Kingdom / Lithuania / Israel / Czech Republic / /
Currency
EUR / /
Event
Business Partnership / M&A / Reorganization / /
IndustryTerm
oncology products / generic pharmaceutical products / treatment of cancers / plant products / main active pharmaceutical ingredient / active pharmaceutical ingredients / pharmaceutical / medicinal products / generic pharmaceuticals / pharmaceuticals / treatment of a particular cancer / active pharmaceutical ingredient / treatment of another type of cancer / generic pharmaceutical / prescription pharmaceuticals / treatment of the same type of cancer / pharmaceutical company specialising / pharmaceutical products / over-the-counter pharmaceuticals / generic products / pharmaceutical firms / /
MedicalCondition
ovarian cancer / breast and lung cancer / colon and ovarian cancer / non-small-cell lung cancer / prostate cancer / breast cancer / cancers / cancer / disease / tumour / particular cancer / /
European Communities COMMISSION OF THE EUROPEAN COMMUNITIES Brussels / European Parliament / European Medicines Agency / 32008M5295 Office for Official L-2985 Luxembourg Publications / European Union / European Society for Medical Oncology / European Pharmaceutical Marketing Research Association / / /
Position
current market leader / producer / market leader / /
m5295_20081219_20212_en.doc